August 2019 - Volume 30 - Issue 7 - Contributor Index

Alphabetical Search
E
Author:
Aieta, Michele
Author:
Aouad, Patrick

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Brighi, Nicole

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Campana, Davide
Author:
Chen, Chunhong
Author:
Dikmen, Miris
Author:
Fabikan, Hannah

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Fangxing, Wu

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Fu, Dongwei
Author:
Fu, Zhenrui
Author:
Gao, Cao
Author:
Gao, Lin
Author:
Gong, Pengchao
Author:
Guo, Huannan
Author:
Han, Bo
Author:
He, Peijie
Author:
He, Xiao-Feng

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Hu, Jing
Author:
Iacono, Daniela
Author:
Jiang, Yan
Author:
Jiao, Meng
Author:
Jiaqiang, Wang
Author:
Ke, Saixiong
Author:
Koger, Renate

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Kong, Cuicui
Author:
Krenbek, Dagmar

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Li, Jiangping
Author:
Li, Yanlan
Author:
Li, Yanlin
Author:
Li, Zhe-Hai
Author:
Liu, Hui
Author:
Liu, Mingyang
Author:
Liu, Yan
Author:
Liu, Yongmin
Author:
Lu, Chao
Author:
Lu, Shi-Bao
Author:
Lv, Lili
Author:
Maggio, Ilaria
Author:
Manuzzi, Lisa
Author:
Mao, Wenjing
Author:
Marra, Arnaldo
Author:
Naber, Jakob

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Palange, Paolo
Author:
Qi, Mei
Author:
Qiao, Baomin
Author:
Qiqing, Cai
Author:
Ricci, Alberto
Author:
Schwab, Sophia

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Setinek, Ulrike

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Shen, Jiang
Author:
Shen, Ying
Author:
Su, Peng
Author:
Sun, Feifei
Author:
Tian, Xin

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Wang, Pengju
Author:
Wang, Weicheng
Author:
Watzka, Stefan

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Wei, Chunsheng

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; More

Anti-Cancer Drugs. 30(7):740-744, August 2019.

Author:
Weitao, Yao
Author:
Wu, Xiufa
Author:
Wu, Zhen
Author:
Xiang, Lei
Author:
Xu, Qing-Rong
Author:
Xu, Yan-Jie
Author:
Yang, Ling
Author:
Yao, Ming
Author:
Zhang, Changwen
Author:
Zhang, Jing
Author:
Zhang, Lan
Author:
Zhang, Wenqian
Author:
Zhao, Limin
Show: